The establishment of this new center aims to expedite R&D processes, reduce costs, and potentially lead to accelerated discovery of new candidate therapies.
The new center's design will prioritize integration of the entire supply chain, with the aim of accelerating product development and autonomous production capacity in alignment with EU priorities.
SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy product.
Thermo Fisher Scientific's launch of its Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.
The next-generation IRO platform was found to significantly outperform the legacy Prodigy system, showing improvements in cell growth, CAR+ cell yield, and overall efficiency.
The latest developments in emerging therapies, including new innovations and collaborative efforts in manufacturing.
Vectura’s expertise in the field includes formulation and device development for dry powder inhalers and pressurized metered dose inhalers, among other products and services.
The company said this new commitment to its facility in Germany goes hand in hand with its recently announced ReciPredict, an initiative intended to streamline the product development cycle.
The critical APIs that this funding will contribute to are used in the treatment of asthma, diabetes, and anxiety disorders.
This is the company’s largest single investment in the Sweden Biomanufacturing Center, in Södertälje, which opened in 2021.